CD8A and COVID-19: Accordingly, the restoration of T lymphocyte homeostasis from immunosenescence and from T cell exhaustion should be pivotal in the development of new and improved immuno-therapies for treating patients with COVID-19, and CD4+ and CD8+ T lymphocyte counts and CD4+ /CD8+ ratio may serve as indicators in evaluating the therapeutic effects of immuno-therapies.